Ironwood醫藥 IRWD 深 滬
等待開盤 09-17 09:30:00 美东时间
4.17
+0.110
+2.71%
華盛通- 最 高4.24
- 今 開4.07
- 成交量 131.28万股
- 最 低 4.06
- 昨 收 4.06
- 總市值 6.89亿
- 52周最高 5.78
- 市盈率 靜 28.29
- 換手率 0.79%
- 52周最低 1.29
- 委 比 -4.72%
- 總股本 1.65亿
- 歷史最高 18.915
- 量 比 1.05
- 振 幅 4.43%
- 歷史最低 0.5271
- 每 手 1
- 風險率 0.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ironwood Pharmaceuticals Raises FY2026 Sales Guidance from $450.000M-$475.000M to $460.000M-$485.000M vs $460.118M Est
Ironwood Pharmaceuticals (NASDAQ:IRWD) raises FY2026 sales outlook from $450.000 million-$475.000 million to $460.000 million-$485.000 million vs $460.118 million estimate.
08-06 19:09
Ironwood Pharmaceuticals Q2 Adj. EPS $0.31 Misses $0.36 Estimate, Sales $113.041M Miss $114.844M Estimate
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.31 per share which missed the analyst consensus estimate of $0.36 by 13.89 percent. This is a 121.43 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $113...
08-06 19:09
Top profitable small caps trading at bargain P/E multiples during Q2 earnings
As the market moves through second-quarter earnings season, investors are paying close attention to small-cap stocks that combine solid profitability with attractive valuations. Price-to-earnings rat...
07-27 21:09
Ironwood Pharma Initiates Phase 3 STARS‑2 Trial Of Apraglutide In Short Bowel Syndrome With Intestinal Failure
– Ironwood Chief Medical Officer and Head of Research and Drug Development Dr. Michael Shetzline to Retire After 30-Year Career Advancing GI Science and Patient Care – – Dr. Silber, a Drug Development Veteran, Will Lead Ironwood’s Next Phase of R&D Strategy and Execution – Ironwood Pharmaceuticals, ...
07-14 19:32
Ironwood Pharma Strengthens Balance Sheet With Note Repayment
Ironwood Pharma ( ($IRWD) ) just unveiled an announcement. On June 15, 2026, Ir...
06-16 05:07
Ironwood Pharmaceuticals Signals Blockbuster Momentum in 2026
Ironwood Pharmaceuticals (($IRWD)) has held its Q1 earnings call. Read on for t...
06-02 08:30
Ironwood, AbbVie win U.S. label expansion for Linzess in pediatric constipation
Ironwood Pharmaceuticals (IRWD) announced on Wednesday that the Food and Drug Administration approved a label expansion for its AbbVie (ABBV)-partnered bowel disorder therapy Linzess to treat children...
05-27 23:00
Small-cap healthcare stocks ranked by quant ratings after earnings season
As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factor...
05-26 22:20
